Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram vs Bupropion XL for Memory in MDD
NCT00296933Phase 3Completed
- Sponsor
- University Health Network
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupropion, escitalopram in major depressive disorder (MDD), sponsored by University Health Network. Started Dec 2005; status: completed.
02
Drugs
bupropionescitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00296933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296933.